Chemomab Therapeutics Ltd. (CMMB) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 26.9K | 0 | 16.17K | 18.94K | 15.82K | 9.05M | 13.96K | 8.32M | 6.25M | 13.03K | 11.05K | 9.04K | 7.03K | 6.93K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | -26.9K | 0 | -16.17K | -18.94K | -15.82K | -9.05M | -13.96K | -8.32M | -6.25M | -13.03K | -11.05K | -9.04K | -7.03K | -6.93K |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | 100% | - | 100% | 100% | -70.07% | 100% | -15.84% | 99.77% | 99.75% | -69358.09% | -26.35% | -91881.86% | -88924.91% | -88.06% | - | - | - | - |
| Operating Expenses | 1.99M | 1.84M | 2.26M | 3.49M | 3.21M | 3.71M | 3.77M | 4.05M | 3.85M | 4.33M | 8.2M | 9.05M | 8.64M | 8.32M | 6.25M | 5.32M | 5.02M | 2.89M | 2.75M | 1.7M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 881K | 884K | 975K | 994K | 802K | 874K | 840K | 896K | 751K | 986.8K | 3.17M | 2.16M | 2.75M | 2.89M | 3.34M | 2.58M | 2.64M | 1.4M | 1.45M | 542K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.1M | 960K | 1.29M | 2.49M | 2.41M | 2.84M | 2.93M | 3.15M | 3.11M | 3.35M | 5.02M | 6.89M | 5.89M | 5.42M | 2.91M | 2.75M | 2.38M | 1.49M | 1.31M | 1.16M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 5.5K | 0 | 0 | 0 | 0 | 0 | 0 | 5K | -17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.99M | -1.84M | -2.26M | -3.49M | -3.21M | -3.71M | -3.77M | -4.05M | -3.85M | -4.37M | -8.2M | -9.06M | -8.64M | -8.32M | -6.25M | -5.32M | -5.02M | -2.89M | -2.75M | -1.7M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 38.18% | 50.3% | 39.97% | 13.86% | 16.5% | 15.04% | 54.02% | 55.34% | 55.47% | 47.49% | -31.04% | -70.39% | -72.01% | -187.69% | -127.17% | -213.13% | -158.7% | -136% | -150.05% | 0.29% |
| EBITDA | -1.98M | -1.84M | -2.26M | -3.47M | -3.21M | -3.69M | -3.75M | -4.03M | -3.83M | -4.35M | -8.18M | -9.05M | -8.63M | -8.3M | -6.24M | -5.31M | -5.01M | -2.88M | -2.75M | -1.69M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 38.38% | 50.07% | 39.75% | 13.83% | 16.31% | 15.06% | 54.1% | 55.45% | 55.59% | 47.61% | -31.07% | -70.51% | -72.11% | -188% | -127.25% | -213.65% | -158.93% | -136.81% | -150.55% | 0.41% |
| D&A (Non-Cash Add-back) | 10.37K | 0 | 0 | 13.25K | 6.25K | 16.75K | 13.5K | 16.75K | 16.17K | 18.94K | 15.82K | 15.85K | 13.96K | 16.86K | 13.84K | 13.03K | 11.05K | 9.04K | 7.03K | 7K |
| EBIT | -1.99M | -1.84M | -2.26M | -3.49M | -3.21M | -3.71M | -3.77M | -4.05M | -3.85M | -4.37M | -8.2M | -9.05M | -8.64M | -8.32M | -6.25M | -5.32M | -5.02M | -2.89M | -2.75M | -1.7M |
| Net Interest Income | 101.63K | 102.48K | 209.27K | 163.15K | 251.99K | 227K | 137K | 180K | 435.67K | 231K | 256.06K | 314.03K | 378.99K | 235.1K | -474.35K | 216K | -12K | -77K | -17K | -4.95K |
| Interest Income | 101.63K | 102.48K | 209.27K | 163.15K | 251.99K | 227.28K | 136.5K | 182K | 435.67K | 230.25K | 256.06K | 314.03K | 378.99K | 235.1K | 0 | 216.47K | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 474.35K | 0 | 12.05K | 77.36K | 17.06K | 4.95K |
| Other Income/Expense | 101.63K | 102K | 205K | 164K | 250K | 227K | 137K | 180K | 431K | 230.26K | 259K | 317K | 380K | 237K | -480K | 216K | -12K | -77K | -17K | -5K |
| Pretax Income | -1.88M | -1.74M | -2.06M | -3.32M | -2.96M | -3.48M | -3.63M | -3.87M | -3.45M | -4.14M | -7.85M | -8.65M | -8.24M | -8.02M | -6.66M | -5.1M | -5.04M | -2.98M | -2.78M | -1.7M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -54.82K | 34K | 21K | 10K | 237K | -544K | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1.33% | -0.43% | -0.24% | -0.12% | -2.96% | 8.17% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.88M | -1.74M | -2.06M | -3.32M | -2.96M | -3.48M | -3.63M | -3.87M | -3.45M | -4.07M | -7.97M | -8.75M | -8.27M | -8.32M | -6.19M | -5.1M | -5.04M | -2.97M | -2.77M | -1.7M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 36.39% | 49.99% | 43.35% | 14.09% | 14.22% | 14.38% | 54.44% | 55.81% | 58.24% | 51.09% | -28.76% | -71.49% | -64.26% | -180.22% | -123.47% | -199.53% | -158.12% | -142.48% | -156.24% | -0.53% |
| Net Income (Continuing) | -1.88M | -1.74M | -2.06M | -3.32M | -2.96M | -3.48M | -3.63M | -3.87M | -3.42M | -4.07M | -7.88M | -8.67M | -8.25M | -8.08M | -6.12M | -5.1M | -5.04M | -2.98M | -2.78M | -1.7M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.24 | -0.28 | -0.36 | -0.58 | -0.63 | -0.80 | -1.01 | -1.10 | -1.06 | -1.38 | -2.84 | -3.14 | -2.84 | -2.78 | -2.13 | -1.76 | -1.77 | -1.05 | -1.03 | -0.86 |
| EPS Growth % | 61.9% | 65% | 64.36% | 47.27% | 40.57% | 42.03% | 64.44% | 64.97% | 62.68% | 50.36% | -33.33% | -78.41% | -60.45% | -164.76% | -106.8% | -104.65% | 62.02% | 80.26% | 86.41% | 88.74% |
| EPS (Basic) | -0.24 | -0.28 | -0.36 | -0.58 | -0.63 | -0.80 | -1.01 | -1.10 | -1.06 | -1.38 | -2.84 | -3.14 | -2.84 | -2.78 | -2.13 | -1.76 | -1.77 | -1.05 | -1.03 | -0.86 |
| Diluted Shares Outstanding | 7.82M | 6.18M | 5.79M | 5.7M | 4.71M | 4.38M | 3.58M | 3.55M | 3.25M | 2.96M | 2.77M | 2.76M | 2.91M | 2.86M | 2.85M | 2.85M | 2.85M | 2.85M | 2.7M | 1.96M |
| Basic Shares Outstanding | 7.82M | 6.18M | 5.79M | 5.7M | 4.71M | 4.38M | 3.58M | 3.55M | 3.25M | 2.96M | 2.77M | 2.76M | 2.91M | 2.86M | 2.85M | 2.85M | 2.85M | 2.85M | 2.7M | 1.96M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |